MedTrace Logo

Safety Study of Adoptive Transfer of Autologous IKDC-like Cells

NCT02661685 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-02-18

No results posted yet for this study

Summary

The purpose of this study is to determine the safety of adoptive transferring autologous IKDC-like cells

Conditions

  • Neoplasm Metastasis

Interventions

BIOLOGICAL

autologous IKDC-like cells

Subject received autologous IKDC-like cells every 14 days

Sponsors & Collaborators

  • Ministry of Science and Technology, Taiwan

    collaborator OTHER_GOV

  • Academia Sinica, Taiwan

    collaborator OTHER

  • National Defense Medical Center, Taiwan

    lead OTHER

Principal Investigators

  • Ming-Shen Dai, MD/PhD · Attending Physician

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02661685 on ClinicalTrials.gov